(Q30228649)

English

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 June 2017

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands (English)

1 reference

Europe PubMed Central

11 June 2017

0 references

1 reference

based on heuristic

inferred from title

pneumococcal vaccine

1 reference

based on heuristic

inferred from title

author name string

Silke David

1

1 reference

Europe PubMed Central

11 June 2017

Patricia E Vermeer-de Bondt

2

1 reference

Europe PubMed Central

11 June 2017

Nicoline A T van der Maas

3

1 reference

Europe PubMed Central

11 June 2017

language of work or name

0 references

publication date

4 September 2008

1 reference

Europe PubMed Central

11 June 2017

1 reference

Europe PubMed Central

11 June 2017

26

1 reference

Europe PubMed Central

11 June 2017

46

1 reference

Europe PubMed Central

11 June 2017

5883-5887

1 reference

Europe PubMed Central

11 June 2017

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Systematic review of the effects of pertussis vaccines in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Standardized case definitions of adverse events following immunization (AEFI)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Performance of the Brighton collaboration case definition for hypotonic-hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate v

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.105

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.07.105

1 reference

Europe PubMed Central

11 June 2017

release_wunktwleufha7gy5rhgoco32iy

1 reference

https://api.fatcat.wiki/v0/release/wunktwleufha7gy5rhgoco32iy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30228649&oldid=1955319265"